Skip to main content
Addgene

pIL2R FAK
(Plasmid #50524)

Full plasmid sequence is not available for this item.

Loading...

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 50524 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pCMVIL2R(pIL2R)
  • Backbone manufacturer
    Bruce Howard Lab, PubMed ID 1373145
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    protein tyrosine kinase, domain
  • Alt name
    FAK
  • Alt name
    PTK2
  • Species
    M. musculus (mouse)
  • Promoter CMV
  • Tag / Fusion Protein
    • IL-2R (N terminal on backbone)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site unknown (not destroyed)
  • 3′ cloning site unknown (not destroyed)
  • 5′ sequencing primer IL2R FW (TCCTGCCTCGTCACAACAAC)
  • 3′ sequencing primer Il2R AS2 (CCTTAGAGCTTTAAATCTCTG)
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Vector contains truncated IL-2R alpha subunit without cytoplasmic domain (Tac antigen) for membrane localization and clustering

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pIL2R FAK was a gift from Kenneth Yamada (Addgene plasmid # 50524 ; http://n2t.net/addgene:50524 ; RRID:Addgene_50524)
  • For your References section:

    Regulation of fibronectin receptor distribution. LaFlamme SE, Akiyama SK, Yamada KM. J Cell Biol. 1992 Apr;117(2):437-47. 10.1083/jcb.117.2.437 PubMed 1373145